Rezultati - Chan, Arlene

Lapatinib - Overview and Current Role in Metastatic Breast Cancer od Chan, Arlene

Polni tekst Polni tekst Polni tekst

Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness od Chan, Arlene

Polni tekst Polni tekst Polni tekst

Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer od Coleman, Robert, Zhou, Ying, Jandial, Danielle, Cadieux, Benoit, Chan, Arlene

Polni tekst Polni tekst Polni tekst

Pigment Epithelium-Derived Factor and Sex Hormone-Responsive Cancers od Brook, Naomi, Brook, Emily, Dass, Crispin R., Chan, Arlene, Dharmarajan, Arun

Polni tekst Polni tekst Polni tekst

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease od Chan, Arlene, Morey, Adrienne, Brown, Belinda, Hastrich, Diana, Willsher, Peter, Ingram, David

Polni tekst Polni tekst Polni tekst

A review of the importance of immune responses in luminal B breast cancer od Nelson, Delia J., Clark, Briony, Munyard, Kylie, Williams, Vincent, Groth, David, Gill, Jespal, Preston, Henry, Chan, Arlene

Polni tekst Polni tekst Polni tekst

Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib od Vogel, Charles, Chan, Arlene, Gril, Brunilde, Kim, Sung-Bae, Kurebayashi, Junichi, Liu, Li, Lu, Yen-Shen, Moon, Hanlim

Polni tekst Polni tekst Polni tekst

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer od De Boer, Richard H., Kotasek, Dusan, White, Shane, Koczwara, Bogda, Mainwaring, Paul, Chan, Arlene, Melara, Rebeca, Ye, Yining, Adewoye, Adeboye H., Sikorski, Robert, Kaufman, Peter A.

Polni tekst Polni tekst Polni tekst

Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer od Dent, Rebecca A, Lindeman, Geoffrey J, Clemons, Mark, Wildiers, Hans, Chan, Arlene, McCarthy, Nicole J, Singer, Christian F, Lowe, Elizabeth S, Watkins, Claire L, Carmichael, James

Polni tekst Polni tekst Polni tekst

Decentralizing PrEP delivery: Implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada od Charest, Maxime, Sharma, Malika, Chris, Allison, Schnubb, Alexandre, Knox, David C., Wilton, James, Shahin, Rita, Chan, Arlene, Mishra, Sharmistha, Grace, Daniel, Bayoumi, Ahmed M., Maxwell, John, Bogoch, Isaac I., Tan, Darrell H. S.

Polni tekst Polni tekst Polni tekst

Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol od Sharma, Malika, Chris, Allison, Chan, Arlene, Knox, David C., Wilton, James, McEwen, Owen, Mishra, Sharmistha, Grace, Daniel, Rogers, Tim, Bayoumi, Ahmed M., Maxwell, John, Shahin, Rita, Bogoch, Isaac, Gilbert, Mark, Tan, Darrell H. S.

Polni tekst Polni tekst Polni tekst

Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer od Burris, Howard A., Chan, Arlene, Bardia, Aditya, Thaddeus Beck, J., Sohn, Joohyuk, Neven, Patrick, Tripathy, Debu, Im, Seock-Ah, Chia, Stephen, Esteva, Francisco J., Hart, Lowell, Zarate, Juan Pablo, Ridolfi, Antonia, Lorenc, Karen Rodriguez, Yardley, Denise A.

Polni tekst Polni tekst Polni tekst

Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study od Fasching, Peter A., Beck, J. Thaddeus, Chan, Arlene, De Laurentiis, Michele, Esteva, Francisco J., Jerusalem, Guy, Neven, Patrick, Pivot, Xavier, Bianchi, Giulia V., Martin, Miguel, Chandiwana, David, Lanoue, Brad, Ridolfi, Antonia, Wang, Yingbo, Rodriguez Lorenc, Karen, Nusch, Arnd

Polni tekst Polni tekst Polni tekst

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast... od Wolff, Antonio C., Lazar, Ann A., Bondarenko, Igor, Garin, August M., Brincat, Stephen, Chow, Louis, Sun, Yan, Neskovic-Konstantinovic, Zora, Guimaraes, Rodrigo C., Fumoleau, Pierre, Chan, Arlene, Hachemi, Soulef, Strahs, Andrew, Cincotta, Maria, Berkenblit, Anna, Krygowski, Mizue, Kang, Lih Lisa, Moore, Laurence, Hayes, Daniel F.

Polni tekst Polni tekst Polni tekst

RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast C... od Baselga, José, Zamagni, Claudio, Gómez, Patricia, Bermejo, Begoña, Nagai, Shigenori E., Melichar, Bohuslav, Chan, Arlene, Mángel, Lászlo, Bergh, Jonas, Costa, Frederico, Gómez, Henry L., Gradishar, William J., Hudis, Clifford A., Rapoport, Bernardo L., Roché, Henri, Patricia, Maeda, Huang, Liping, Meinhardt, Gerold, Zhang, Joshua, Schwartzberg, Lee S.

Polni tekst Polni tekst Polni tekst

Health-Related Quality of Life With Adjuvant Docetaxel- and Trastuzumab-Based Regimens in Patients with Node-Positive and High-Risk Node-Negative, HER2-Positive Early Breast Cancer... od Au, Heather-Jane, Eiermann, Wolfgang, Robert, Nicholas J., Pieńkowski, Tadeusz, Crown, John, Martin, Miguel, Pawlicki, Marek, Chan, Arlene, Mackey, John, Glaspy, John, Pintér, Tamás, Liu, Mei-Ching, Fornander, Tommy, Sehdev, Sandeep, Ferrero, Jean-Marc, Bée, Valerie, Santana, Maria J., Miller, Dave P., Lalla, Deepa, Slamon, Dennis J.

Polni tekst Polni tekst Polni tekst

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negati... od Baselga, José, Gómez, Patricia, Greil, Richard, Braga, Sofia, Climent, Miguel A., Wardley, Andrew M., Kaufman, Bella, Stemmer, Salomon M., Pêgo, António, Chan, Arlene, Goeminne, Jean-Charles, Graas, Marie-Pascale, Kennedy, M. John, Ciruelos Gil, Eva Maria, Schneeweiss, Andreas, Zubel, Angela, Groos, Jutta, Melezínková, Helena, Awada, Ahmad

Polni tekst Polni tekst Polni tekst

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer—The Evaluating Treatment With Neoadjuvant... od Gianni, Luca, Mansutti, Mauro, Anton, Antonio, Calvo, Lourdes, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chacon, Jose Ignacio, Chan, Arlene, Morales, Serafin, Alvarez, Isabel, Plazaola, Arrate, Zambetti, Milvia, Redfern, Andrew D., Dittrich, Christian, Dent, Rebecca Alexandra, Magazzù, Domenico, De Fato, Raffaella, Valagussa, Pinuccia, Tusquets, Ignacio

Polni tekst Polni tekst Polni tekst

An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer od Vacirca, Jeffrey L., Chan, Arlene, Mezei, Klára, Adoo, Clarence S., Pápai, Zsuzsanna, McGregor, Kimberly, Okera, Meena, Horváth, Zsolt, Landherr, László, Hanslik, Jerzy, Hager, Steven J., Ibrahim, Emad N., Rostom, Makharadze, Bhat, Gajanan, Choi, Mi Rim, Reddy, Guru, Tedesco, Karen L., Agajanian, Richy, Láng, István, Schwartzberg, Lee S.

Polni tekst Polni tekst Polni tekst

Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer od Ocaña, Alberto, Chacón, Jose Ignacio, Calvo, Lourdes, Antón, Antonio, Mansutti, Mauro, Albanell, Joan, Martínez, María Teresa, Lahuerta, Ainhara, Bisagni, Giancarlo, Bermejo, Begoña, Semiglazov, Vladimir, Thill, Marc, Chan, Arlene, Morales, Serafin, Herranz, Jesús, Tusquets, Ignacio, Chiesa, Massimo, Caballero, Rosalía, Valagussa, Pinuccia, Bianchini, Giampaolo, Alba, Emilio, Gianni, Luca

Polni tekst Polni tekst Polni tekst